Figen DORAN, Fatih KÖKSAL, Maryam YAASI, Suna KIZILYILDIRIM, Mohammad HOSSEIN SOMI, Amirtaher EFTEKHARSADAT, Mahsa ESMAEILLOU, Başak BEDİR, Ali BAHADORI

Comparative analysis of selected cagPAI genes and different vacA genotypes in Iranian and Turkish H. pylori-positive patients suffering from gastric adenocarcinoma and active chronic gastritis

Background/aim: Helicobacter pylori is a pathogen that colonizes a majority of the world s population. Genetic diversity within the virulence genes of bacteria such as cagPAI and vacA may have a modified effect on the pathogenic potential of the bacteria. This study aimed to investigate which genes can be suggested as potentially related virulence factors for H. pylori-associated active chronic gastritis and stomach adenocarcinoma in the northwest of Iran and south of Turkey. Materials and methods: Formalin-fixed, paraffin-embedded stomach biopsy tissue samples were obtained from Iranian and Turkish patients from selected geographical regions. The prevalence of selected cagPAI genes and vacA genotypes were studied in H. pyloripositive samples by using polymerase chain reaction and specific primers. Results: Out of 320 patients, H. pylori was detected in 28.43% of patients. We found that the vacAs1, vacAm2, and cagA genes with mean prevalences of 82.41%, 71.42%, and 69.23%, respectively, were dominant in Iranian and Turkish patients. Conclusion: In the south of Turkey and northwest of Iran the studied genes were homogeneous and there were no significant differences in bacterial genetics. The results of this study indicate that cagA and vacAs1 are dominant genes in people with gastric disorders in our selected geographical regions.

PDF

___

1. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 321: 1273- 1275.
2. Kusters JG, van Vliet, AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449- 490.
3. Marshall B, Warren JR, Blincow E, Phillips M, Goodwin CS, Murray R, Blackbourn S, Waters T, Sanderson C. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 332: 1437-1442.
4. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. P Natl Acad Sci USA 2002; 99: 14428-14433.
5. Werner M, Becker KF, Keller G, Höfler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 2001; 127: 207-216.
6. Hussein NR, Mohammadi M, Talebkhan Y, Doraghi M, Letle DP, Muhammad MK, Argent RH, Atherton JC. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol 2008; 46: 1774-1779.
7. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999; 284: 1328-1333.
8. Blaser MJ. Helicobacter pylori and gastric diseases. BMJ 1998; 316: 1507-1510.
9. Ji X, Fernandez T, Burroni D, Pagliaccia C, Atherton JC, Reyrat JM, Rappuoli R. Cell specificity of Helicobacter pylori cytotoxin is determined by a short region in the polymorphic midregion. Infect Immun 2000; 68: 3754-3757.
10. Pagliaccia C, De Bernard M, Lupetti P, Ji X, Burroni D, Cover TL, Papini E, Rappuoli R, Telford JL, Reyrat JM. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. P Natl Acad Sci USA 1998; 95: 10212- 10217.
11. Van Doorn LJ, Figueiredo C, Sanna R, Pena S, Midolo P, Atherton JC, Blaser MJ, Quint WG. Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 2000; 38: 2464.
12. Rabelo-Gonçalves E, Roesler B, Guardia AC, Milan A, Hara N, Escanhoela C, Almeida J, Boin I. Evaluation of five DNA extraction methods for detection of H. pylori in formalin-fixed paraffin-embedded (FFPE) liver tissue from patients with hepatocellular carcinoma. Pathol Res Pract 2014; 210: 142-146.
13. Alikhani MY, Arebestani MR, Khorasani MS, Majlesi A, Jaefari M. Evaluation of Helicobacter pylori vacA and cagA genotypes and correlation with clinical outcome in patients with dyspepsia in Hamadan Province, Iran. Iran Red Crescent Med J 2014; 16: e19173.
14. Baghaei K, Shokrzadeh L, Jafari F, Dabiri H, Yamaoka Y, Bolfion M, Zojaji H, Aslani MM. Determination of Helicobacter pylori virulence by analysis of the cag pathogenicity island isolated from Iranian patients. Dig Liver Dis 2009; 41: 634-638.
15. Douraghi M, Mohammadi M, Shirazi MH, Oghalaie A, Kashani SS, Mohagheghi MA, Hosseini ME, Zeraati H, Esmaili M, Bababeik M. Simultaneous detection of cagA and cagE of Helicobacter pylori strains recovered from Iranian patients with different gastroduodenal diseases. Iranian J Publ Health 2009; 38: 98-105.
16. Roesler BM, Zeitune JMR. From gastritis to gastric cancer: the importance of CagPAI of Helicobacter Pylori on the development of early and advanced gastric adenocarcinoma. In: Mozsik G, editor. Current Topics in Gastritis. Rijeka, Croatia: InTech; 2012. p. 224.
17. Hsu PI, Hwang IR, Cittelly D, Lai KH, El-Zimaity HM, Gutierrez O, Kim JG, Osato MS, Graham DY. Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol 2002; 97: 2231-2238.
18. Nagiyev T, Yula E, Abayli B, Koksal F. Prevalence and genotypes of Helicobacter pylori in gastric biopsy specimens from patients with gastroduodenal pathologies in the Cukurova region of Turkey. J Clin Microbiol 2009; 47: 4150-4153.
19. Talebkhan Y, Mohammad M, Mohagheghi MA, Vaziri HR, Hosseini ME, Mohajerani N, Oghalaei A, Esmaeili M, Zamaninia L. cagA gene and protein status among Iranian Helicobacter pylori strains. Dig Dis Sci 2008; 53: 925-932.
20. Mukhopadhyay AK, Kersulyte D, Jeong JY, Datta S, Ito Y, Chowdhury A, Chowdhury S, Santra A, Bhattacharya SK, Azuma T et al. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol 2000; 182: 3219-3227.
21. Souod N, Kargar M, Doosti A, Ranjbar R, Sarshar M. Genetic analysis of cagA and vacA genes in Helicobacter pylori isolates and their relationship with gastroduodenal diseases in the west of Iran. Iran Red Crescent Med J 2013; 15: 371.
22. Ghotaslou R, Milani M, Akhi MT, Nahaei MR, Hasani A, Hejazi MS, Meshkini M. Diversity of Helicobacter pylori cagA and vacA genes and its relationship with clinical outcomes in Azerbaijan, Iran. Adv Pharm Bull 2013; 3: 57-62.
23. Vaziri F, Najar Peerayeh S, Alebouyeh M, Mirzaei T, Yamaoka Y, Molaei M, Maghsoudi N. Diversity of Helicobacter pylori genotypes in Iranian patients with different gastroduodenal disorders. World J Gastroenterol 2013; 19: 5685-5692.
24. Saltık İN, Demir H, Engin D, Ertunç ÖD, Akyön Y, Koçak N. The cagA status of Helicobacter pylori isolates from dyspeptic children in Turkey. FEMS Immunol Med Microbiol 2003, 36: 147-149.
25. Lei DH, Huang LP, Duan YJ, Guo G. Helicobacter pylori chaperone-like protein CagT plays an essential role in the translocation of CagA into host cells. J Microbiol Bacteriol 2012; 22: 1343-1349.
26. Fischer W, Pül J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin‐8. Mol Microbiol 2001; 42: 1337-1348.
27. Hussein NR, Mohammadi M, Talebkhan Y, Doraghi M, Letley DP, Muhammad MK, Argent RH, Atherton JC. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol 2008; 46: 1774-1779.
28. Godfrey TE, Kim SH, Chavira M, Ruff DW, Warren RS, Gray JW, Jensen RH. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn 2000; 2: 84-91.
29. Lima VP, de Lima Silva-Fernandes IJ, Alves MKS, Rabenhorst SHB. Prevalence of Helicobacter pylori genotypes (vacA, cagA, cagE and virB11) in gastric cancer in Brazilians patients: an association with histopathological parameters. Cancer Epidemiol 2011; 35: e32-e37.
30. Sedaghat H, Moniri R, Jamali R, Arj A, Zadeh MR, Moosavi SGA, Rezaei M. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2, and oipA genotypes in patients with upper gastrointestinal diseases. Iran J Microbiol 2014; 6: 14.
31. Erdogu C, Saribash Z, Yilmaz YA. Detection of cagA and vacA genotypes of Helicobacter pylori isolates from a university hospital in Ankara region, Turkey. Turk J Med Sci 2014; 44: 126-132.
32. Ozbey G, Demirel U, Aygun C, Ertas HB. Investigation of the association between clinical outcome and the cag pathogenicity-island and other virulence genes of Helicobacter pylori isolates from patients with dyspepsia in Eastern Turkey. Braz J Microbiol 2013; 44: 1267-1274.